K. Lizis-Kolus

发表

The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer

J. Kopczyński, S. Góźdź, A. Kowalik, 2018, PloS one.

Delayed risk stratification system in pT1aN0/Nx DTC patients treated without radioactive iodine

J. Kopczyński, S. Góźdź, A. Kowalik, 2017, Endocrine connections.

The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer Recurrence

S. Góźdź, A. Kowalska, R. Mężyk, 2016, PloS one.

Response to therapy of papillary thyroid cancer of known BRAF status

J. Kopczyński, S. Góźdź, A. Kowalik, 2017, Clinical endocrinology.

CHEK2 mutations and the risk of papillary thyroid cancer

Ping Sun, Artur Kowalik, Cezary Cybulski, 2015, International journal of cancer.

Case report of a woman with monoclonal gammapathy and papillary thyroid carcinoma, diagnosed because of detection of CHEK2 (I157T) mutation in genetic examinations.

J. Lubiński, C. Cybulski, B. Kozak-Klonowska, 2010, Endokrynologia Polska.

[The POEMS syndrome with coexisting endocrinopathy--case report].

A. Kowalska, Maria Nowakowska-Domagala, K. Lizis-Kolus, 2007, Endokrynologia Polska.

How much of the predisposition to Hashimoto’s thyroiditis can be explained based on previously reported associations?

A. Hubalewska-Dydejczyk, D. Pach, P. Kapusta, 2018, Journal of Endocrinological Investigation.

Malignant pheochromocytoma with brain metastases and coexisting meningioma: case report

A. Kowalska, K. Lizis-Kolus, 2009 .

Comparative assessment of calcitonin stimulation test using calcium gluconate and pentagastrin and the usefulness of procalcitonin basic and post-stimulation concentrations in the diagnosis of patients after surgery for medullary.

S. Góźdź, A. Kowalska, R. Mężyk, 2016, Neuro endocrinology letters.

The usefulness of determining the presence of BRAF V600E mutation in fine-needle aspiration cytology in indeterminate cytological results.

J. Kopczyński, S. Góźdź, A. Kowalik, 2016, Endokrynologia Polska.